Industries > Pharma > Translational Regenerative Medicine Market Forecast 2020-2030

Translational Regenerative Medicine Market Forecast 2020-2030

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 31 January 2020
PAGES: 338
PRODUCT CODE: PHA0670

Clear
WOOCS 2.2.1

covid-19

The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 24% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 59% in 2019.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report you will find 338-page report and you will receive 116 tables, 104 figures and 3 interviews – all unavailable elsewhere.

The 338-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Translational Regenerative Medicine market forecasts from 2020-2030

• Global Translational Regenerative Medicine submarket forecasts from 2020-2030 covering:
• Stem Cell Therapies
• Tissue Engineered Products
• Gene Therapies

This study discusses the late-stage clinical trials and pipeline as well as market drivers and restraints of each submarket.

• Translational Regenerative Medicine regional and national market forecasts from 2020-2030, covering:
• North America: US, Canada
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa

Translational Regenerative Medicine Market Forecast 2020-2030

Each regional market is further segmented by sector.

• Forecasts from 2020-2030 of the selected leading products in the Global Translational Regenerative Medicine market:
• Osteocel Plus
• Trinity ELITE
• TEMCELL /Prochymal
• Apligraf
• Dermagraft
• Epifix
• ReCell
• Neovasculgen
• IMLYGIC (talimogene laherparepvec)

• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
• Astellas Pharma
• Athersys
• Avita Medical
• AxoGen, Inc.
• MEDIPOST Co., Ltd.
• NuVasive
• Organogenesis Holdings, Inc.
• Osiris Therapeutics, Inc.
• Pharmicell Co., Ltd.
• Takeda
• uniQure N.V.
• Vericell Corporation

• Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.

SWOT and Porter’s Five Force analysis of the translational regenerative medicine market

Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.

Buy our report today Translational Regenerative Medicine Market: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Translational Regenerative Medicine Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Translational Regenerative Medicine Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories